Ticker > Company >

Natural Capsules share price

Natural Capsules Ltd.

NSE: NATCAPSUQ BSE: 524654 SECTOR: Pharmaceuticals & Drugs  23.4 K   64   4

211.99
+5.39 (2.61%)
NSE: Today, 09:34 AM

Price Summary

Today's High

₹ 213.77

Today's Low

₹ 208

52 Week High

₹ 274.75

52 Week Low

₹ 164

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

219.22 Cr.

Enterprise Value

271.52 Cr.

No. of Shares

1.03 Cr.

P/E

28.21

P/B

1.3

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  162.88

CASH

2.71 Cr.

DEBT

55.01 Cr.

Promoter Holding

51.26 %

EPS (TTM)

₹  7.52

Sales Growth

9.19%

ROE

4.51 %

ROCE

7.41%

Profit Growth

-14.02 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Natural Capsules Ltd.

Veenat Lenalid Erlonat Geftinat Sorafenat Bortenat

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.19%
3 Year7.53%
5 Year22.23%

Profit Growth

1 Year-14.02%
3 Year-21.28%
5 Year50.91%

ROE%

1 Year4.51%
3 Year9.72%
5 Year12.03%

ROCE %

1 Year7.41%
3 Year12.12%
5 Year14.77%

Debt/Equity

0.3316

Price to Cash Flow

12.16

Interest Cover Ratio

2.5264

CFO/PAT (5 Yr. Avg.)

0.996090846171593

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 51.26 0.00
Mar 2025 51.21 0.00
Dec 2024 51.14 0.00
Sep 2024 51.60 0.00
Jun 2024 56.56 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 24.8249 days.
  • The company has a high promoter holding of 51.26%.

 Limitations

  • The company has shown a poor profit growth of -21.6511364730087% for the Past 3 years.
  • The company has shown a poor revenue growth of 7.53138552929635% for the Past 3 years.
  • Company has contingent liabilities of 70.8283 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 39.14 41.03 43.41 44.36 44.24
Total Expenditure 34.42 36.09 38.83 39.31 39.11
Operating Profit 4.72 4.94 4.59 5.05 5.13
Other Income 0.77 0.77 1.15 1.55 1.69
Interest 1.46 1.54 1.39 1.53 1.36
Depreciation 2.09 2.16 2.14 1.94 1.99
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.94 2.02 2.21 3.13 3.48
Tax 0.48 1.09 0.51 0.51 0.96
Profit After Tax 1.46 0.92 1.7 2.63 2.52
Adjusted EPS (Rs) 1.56 0.9 1.65 2.54 2.44

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 79.51 135.07 172.87 153.81 167.94
Total Expenditure 68.38 110.66 138.17 134.53 148.63
Operating Profit 11.14 24.41 34.7 19.28 19.31
Other Income 0.73 2.14 2.12 4.77 4.41
Interest 0.54 2.08 3.88 5.09 6.09
Depreciation 4.31 5.04 7.2 8.57 8.33
Exceptional Items 2.18 0 0 0 0
Profit Before Tax 9.19 19.43 25.74 10.39 9.3
Tax 2.24 5.47 6.55 2.59 2.59
Net Profit 6.88 13.76 19.2 7.81 6.71
Adjusted EPS (Rs.) 9.14 19.9 20.7 8.36 6.49

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 6.23 7.01 9.28 9.33 10.34
Total Reserves 55.9 76.04 114.78 122.53 155.98
Borrowings 0 14.75 23.01 26.47 19.99
Other N/C liabilities 1.55 2.28 3.18 3.39 6.3
Current liabilities 32.98 43.41 60.15 69.54 75.47
Total Liabilities 96.66 143.49 210.4 231.26 268.08
Assets
Net Block 34.59 62.94 93.22 90.51 88.16
Capital WIP 3.45 1.07 0 2.12 0
Intangible WIP 0 0 0 0 0
Investments 0.02 0.05 20.01 22.74 22.74
Loans & Advances 1.47 21.6 21.52 24.1 60.03
Other N/C Assets 0.78 0.41 1 0.57 0.53
Current Assets 56.35 57.42 74.65 91.23 96.62
Total Assets 96.66 143.49 210.4 231.26 268.08
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 9.19 19.43 25.74 10.39 9.3
Adjustment 2.73 6.33 9.9 11.96 10.93
Changes in Assets & Liabilities -3.91 -15.92 -10.09 -14.99 -0.12
Tax Paid -2.22 -4.74 -5.46 -1.97 -2.07
Operating Cash Flow 5.78 5.09 20.1 5.4 18.03
Investing Cash Flow -8.54 -30.42 -55.42 -10.84 -34.37
Financing Cash Flow 2.52 26.51 34.45 7.23 14.81
Net Cash Flow -0.24 1.18 -0.87 1.79 -1.53

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 56.56 51.60 51.14 51.21 51.26
chandra rameshwar laddha 0.01 0.01 0.01 0.01 0.01
indra mundra 4.19 3.82 3.79 3.79 3.79
jyoti mundra 3.28 2.99 2.97 2.97 2.97
jyotsna daga 0.40 - - 0.37 0.37
laxminarayan moondra 2.57 2.35 2.33 2.33 2.33
madhav mundra 1.77 1.61 1.60 1.60 1.60
nandi synthetics pvt ltd 9.83 - 8.89 8.89 8.89
nidhi sethia 0.20 0.18 0.18 0.18 0.18
radha s mundra 2.56 2.34 2.32 2.32 2.32
satyanarayan mundra 1.98 1.80 1.79 1.79 1.79
sharada mundra 2.83 2.59 2.56 2.56 2.56
shrey mundra 1.77 1.61 1.60 1.60 1.60
sunil laxminaryan mundra 6.30 5.75 5.70 5.77 5.82
sushil kumar mundra 5.44 4.97 4.92 4.92 4.92
tajos investments private... 13.41 12.23 12.12 12.12 12.12
jyotsna daga - 0.37 0.37 - -
nandi synthetics pvt ltd ... - 8.97 - - -
mukund gattani 0.01 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 43.44 48.40 48.86 48.79 48.74
anurag singhi - - - - 1.29
investor education and pr... 1.23 1.12 1.20 1.20 1.20
llp - - - - 0.08
narendra dharmsinh sampat... - 1.46 1.45 - 1.45
pcg finvest private ltd - - 1.61 1.61 1.61
sangeetha s 3.50 3.19 3.16 3.16 3.16
tarinika management llp - 3.25 3.22 3.22 3.22
vivog commercial limited 1.67 1.52 1.44 1.44 1.44
anurag singhi - - - 1.13 -
pcg finvest private limit... - 1.63 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY23
Presentation Q3FY24
Presentation Q3FY23

Company News

Natural Capsules informs about investor presentation 5 Aug, 9:36 AM Natural Capsules informs about press release 5 Aug, 9:29 AM Natural Capsules - Quaterly Results 4 Aug, 7:05 PM Natural Capsules - Quaterly Results 4 Aug, 7:05 PM Natural Capsules informs about earnings call transcript 11 Jun, 2:46 PM Natural Capsules informs about secretarial compliance report 30 May, 12:26 PM Natural Capsules - Quaterly Results 12 Feb, 5:45 PM Natural Capsules - Quaterly Results 12 Feb, 5:45 PM Natural Capsules - Quaterly Results 13 Aug, 6:05 PM Natural Capsules - Quaterly Results 13 Aug, 6:05 PM Natural Capsules informs about press release 4 Jul, 5:20 PM Natural Capsules informs about closure of trading window 27 Jun, 12:48 PM Natural Capsules - Quaterly Results 21 May, 7:22 PM Natural Capsules - Quaterly Results 21 May, 7:22 PM Natural Capsules informs about investor meet 20 May, 4:39 PM Natural Capsules informs about loss of share certificate 24 Apr, 5:48 PM Natural Capsules - Quaterly Results 9 Feb, 5:53 PM Natural Capsules - Quaterly Results 9 Feb, 5:53 PM Natural Capsules informs about loss of share certificate 18 Jan, 11:43 AM Natural Capsules informs about press release 10 Nov, 10:15 AM Natural Capsules, its arm enter into agreement with O2 Renewable Energy VIII, O2 Energy SG Pte 30 Sep, 4:58 PM Natural Capsules’ arm inaugurates small volume production, R&D blocks 21 Sep, 6:09 PM Natural Capsules informs about details of loss of certificate 14 Sep, 4:24 PM Natural Capsules informs about newspaper publication 17 Aug, 5:19 PM Natural Capsules informs about investor presentation 10 Aug, 10:24 AM Natural Capsules - Quaterly Results 9 Aug, 7:02 PM Natural Capsules - Quaterly Results 9 Aug, 7:02 PM Natural Capsules informs about summary of proceedings 28 Jul, 4:33 PM Somerset Indus Capital Partners makes investment in Natural Capsules’ arm 22 Jun, 4:10 PM Natural Capsules informs about earnings conference call 3 Jun, 1:36 PM Natural Capsules informs about details of loss of certificate 3 May, 3:11 PM Natural Capsules informs about annual disclosure 28 Apr, 4:25 PM Natural Capsules informs about loss of share certificate 22 Apr, 12:02 PM Natural Capsules informs about details of loss of certificate 28 Feb, 4:13 PM Natural Capsules - Quaterly Results 13 Feb, 6:01 PM Natural Capsules - Quaterly Results 13 Feb, 6:01 PM Natural Capsules informs about trading window closure 29 Dec, 3:03 PM Natural Capsules’ arm completes maiden fund raise of Rs 18.75 crore 21 Nov, 5:15 PM Natural Capsules - Quaterly Results 28 Oct, 7:13 PM Natural Capsules - Quaterly Results 28 Oct, 7:13 PM Natural Capsules informs about board meeting 21 Oct, 9:53 AM Natural Capsules informs about meeting updates 20 Sep, 4:27 PM Natural Capsules informs about outcome of AGM 20 Sep, 1:35 PM Natural Capsules informs about loss of share certificate 15 Sep, 5:17 PM Natural Capsules informs about loss of share certificate 13 Sep, 4:57 PM Natural Capsules informs about newspaper cuttings 12 Aug, 10:26 AM Natural Capsules informs about loss of his share certificate 28 Jul, 5:02 PM Natural Capsules informs about compliances-certificate 16 Jul, 4:44 PM Natural Capsules informs about loss of share certificate 29 Jun, 3:34 PM Natural Capsules informs about details of loss of certificate 23 Jun, 4:13 PM

Natural Capsules Stock Price Analysis and Quick Research Report. Is Natural Capsules an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Natural Capsules. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Natural Capsules has a PE ratio of 27.4894885305232 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Natural Capsules has ROA of 2.688% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Natural Capsules has a Current ratio of 1.2803.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Natural Capsules has a ROE of 4.5092%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Natural Capsules has a Debt to Equity ratio of 0.3316 which means that the company has low proportion of debt in its capital.

  • Sales growth: Natural Capsules has reported revenue growth of 9.1881% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Natural Capsules for the current financial year is 11.4980987053571%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Natural Capsules is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Natural Capsules is Rs 7.5156. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Natural Capsules in Ticker for free. Also, one can get the intrinsic value of Natural Capsules by using Valuation Calculators, which are available with a Finology ONE subscription. 

Natural Capsules FAQs

Q1. What is Natural Capsules share price today?
Ans: The current share price of Natural Capsules is Rs 206.6.

Q2. What is the market capitalisation of Natural Capsules?
Ans: Natural Capsules has a market capitalisation of Rs 213.64824164 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Natural Capsules?
Ans: The PE ratio of Natural Capsules is 27.4894885305232 and the P/B ratio of Natural Capsules is 1.26842391881596, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Natural Capsules share?
Ans: The 52-week high share price of Natural Capsules is Rs 274.75, and the 52-week low share price of Natural Capsules is Rs 164.

Q5. Does Natural Capsules pay dividends?
Ans: Currently, Natural Capsules does not pay dividends. Dividend yield of Natural Capsules is around 0%.

Q6. What are the face value and book value of Natural Capsules shares?
Ans: The face value of Natural Capsules shares is Rs 10, while the book value per share of Natural Capsules is around Rs 162.8793. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Natural Capsules?
Ans: Natural Capsules has a total debt of Rs 55.0094 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Natural Capsules?
Ans: The ROE of Natural Capsules is 4.5092% and ROCE of Natural Capsules is 7.4129%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Natural Capsules a good buy for the long term?
Ans: The Natural Capsules long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Natural Capsules undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Natural Capsules appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Natural Capsules’s financials?
Ans: You can review Natural Capsules’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Natural Capsules
X